Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Histamine dihydrochloride by AgoneX Biopharmaceuticals for Alzheimer's Disease: Likelihood of Approval
Histamine dihydrochloride is under clinical development by AgoneX Biopharmaceuticals and currently in Phase I for Alzheimer's Disease. According to GlobalData,...